Quris AI

We are excited to welcome Quris AI, the latest company to join the AstraZeneca BioVentureHub at the Gothenburg R&D site. Quris AI combines Bio and AI capabilities to provide safer, more effective, and more personalized drugs to patients faster, leveraging their patented AI-driven patient-on-chip platform. Led by a team of pioneers in machine learning, big data, organ-on-chip, biotech, genomics, technology, and pharma, Quris brings together the best of both worlds: Bio and AI. By joining the BioVentureHub, Quris will form a new, fast-growing team, situated at the AstraZeneca Gothenburg R&D site in Sweden, with access to state-of-the-art facilities, infrastructure, R&D knowledge, and expertise. We are looking forward to seeing the team join in, grow and contribute to, and benefit from, the “dare-to-share” culture in the BioVentureHub community. It is also exciting to collaborate within the A.Catalyst Network, a dynamic AstraZeneca network of solutioners and innovative minds from around the globe, and in this particular case the BeyondBio innovation hub. Warm welcome! #Welcome #NewCompany #Quris #Bio #AI #PatientOnChip #ACatalystNetwork #BeyondBio #AccesTo #GrowingInnovationTogether #NewKidsInTown Magnus R. Björsne, Isaac Bentwich, Amir Bein, Sharon Ein-Gal, Ulrika Edvardsson, Robert Börjes, Pernilla Isberg, Emma Wiesel, Erica Woodrow, Anders Persson, Madeleine Thun , Mia Ekdahl

The 23rd Annual Bio-IT World Conference & Expo is coming to Boston this April 15-17, 2024 to explore the best of the technologies and science driving precision medicine! We hope to see you! ✅Hear from 300+ distinguished speakers who look forward to sharing their expertise across 10 Bio-IT Focused Conference Tracks, 9 technical workshops, and 6 Full-Day Deep Dive Symposia. Topics and themes range from #GenerativeAI, #DigitalTwins / #HumanVirtualModels, #AI for #DrugDiscovery and #DrugDevelopment, #FAIRData, #QuantumComputing, #DataScience, and more! ✅Share your best practices and network during three days of interactive discussion. The event attracts a highly influential audience comprising a community of leading #lifesciences, #pharmaceutical, clinical, healthcare, informatics, and technology experts in the fields of #biomedicalresearch, drug discovery & development, and healthcare from around the world. Over 3,000 attendees from 30+ countries will be there! ✅Get inspired by a stellar plenary program that explores important topics of HPC, AI, and data analytics to drive innovation in biomedical informatics and precision medicine; advancing genomic medicine through collaboration on a global scale, and film and social media influence on real-world scientific progress and innovation.   ✅Explore our Exhibit Hall of 150+ exhibitors displaying innovative technologies and solutions! Get in-person insight into how these new solutions can serve you.    ✅Keep up to date on the latest scientific advances with a poster session featuring cutting-edge research from academic and industry professionals.   ✅Discover insights on strategic investments and funding activities in cutting-edge technologies during an exclusive event tailor-made for Venture Capitalists, Private Equity professionals, Banks Investors, and CEOs - Bio-IT World: Venture, Innovation & Partnering Conference.   ✅See winners of our two Awards Programs (Innovative Practices Awards and Best of Show Awards) who are recognized for having an innovative, technology, tool, or solution that pushes the life sciences industry forward, solves problems, and advances precision medicine.   Join us! Don't miss out on the conversations, connections and collaborations with our community of leading life sciences and technology experts from around the world.   Event details: www.bio-itworldexpo.com/   #BioITExpo @bioitworld #lifesciences #biopharma

SLAS2024 speaker update: How tech is reducing failure rates in clinical trials DDW can now reveal the sixth speaker on the programme: physician and entrepreneur Dr Isaac Bentwich, Founder and CEO of Quris AI. Dr Bentwich will present on ‘How artificial intelligence and patient-on-a-chip are improving drug development’ on Tuesday 6 February at 3pm.   His presentation will explore the impact of Quris-AI's Bio-AI platform in the field of drug development. Delegates will hear how the integration of AI with technologies like patient-on-a-chip, real-time nano-sensing and stem cell genomic diversity is addressing the critical challenge of predicting drug behaviour in humans.   What you will learn: - The role of technologies like patient-on-a-chip, real-time nano-sensing and stem cell genomic diversity - The importance of AI for mitigating high failure rates in clinical trials - How platforms can predict drug behaviour in humans Register your interest https://hubs.li/Q02cX_C60 Co-sponsored by INTEGRA Biosciences and Hamamatsu Corporation #SLAS2024 #DrugDiscovery #ClinicalTrials SLAS (Society for Laboratory Automation and Screening)